INTERNATIONAL Faculty
Prof Greta Dreyer
Prof Greta Dreyer is full professor and chair of Gynaecologic Oncology and Gynaecology at Steve Biko Hospital and actively involved in academic medicine as a clinician, researcher and teacher. She studied medicine and specialised at the University of Pretoria, had further training in women’s cancer surgery and treatment locally and in Leuven, Edinburgh and Utrecht, and holds a PhD in cellular cancer genetics.
Prof Dreyer collaborates with prominent South African, European and Australian universities currently focusing on effective cancer prevention, inherited cancer risk, and advanced or salvage surgery. She leads the Women’s Cancer Research Group at UP and the VACCS multicentric and multi-disciplinary national consortium.
She is recipient of several research awards and grants, and a NRF-rated researcher. Prof Dreyer started and edited two peer reviewed scholarly journals, a textbook, and has authored several textbook chapters and more than hundred peer reviewed publications. She has also received recognition for her contribution to training and outreach. Career highlights include training the first SA College-examined and part-time subspecialists, many local, regional and international fellows and numerous M&D graduates.
Prof Greta Dreyer is full professor and chair of Gynaecologic Oncology and Gynaecology at Steve Biko Hospital and actively involved in academic medicine as a clinician, researcher and teacher. She studied medicine and specialised at the University of Pretoria, had further training in women’s cancer surgery and treatment locally and in Leuven, Edinburgh and Utrecht, and holds a PhD in cellular cancer genetics.
Prof Dreyer holds leadership roles in the School of Medicine, Faculty of Heath Care Sciences, College of Obstetrics and Gynaecology and serves nationally and internationally as FIGO Councillor, South African Societies of Gynaecologic Oncology and Obstetrics and Gynaecology Past President and is the International Gynecologic Cancer Society President for 2024-2026.
Prof Sudha sundar
Sudha Sundar is a gynaecological cancer surgeon and a clinical academic. Her research programme focusses on improving cancer diagnostics, cancer surgery and addressing inequalities in cancer outcomes. Sudha’s research has led to change of NICE guidance in 2023 to recommend maximum cytoreduction surgery for ovarian cancer. She has served as the President of the British Gynaecological Cancer Society (2019-2022), the first women gynaecological oncologist to be elected to this post.
She is now National Ovarian Cancer audit surgical lead (2023 – to date) and is spearheading the innovative use of routinely collected data to improve outcomes for women with ovarian cancer.
She has co-chaired the International Gynaecological cancer society conference Scientific program committee in 2024 and is on the International advisory board of Lancet Oncology (2025-). She is shortly to start as Vice Chair at the Education Committee for the International Gynaecological cancer society ( Nov 25-) . She serves on several grant funding panels in the UK and EU.
local faculty
To be announced soon!